Spectrascience seeks approval for colon cancer:
This article was originally published in Clinica
Executive Summary
Spectrascience has said it has enough data from a clinical trial of its Optical Biopsy system for detecting colon cancer to apply for US approval. The company will file a premarket approval application with the FDA by the end of the first quarter of 1998.